                                    COURT OF CHANCERY
                                             OF THE
                                    STATE OF DELAWARE

ANDRE G. BOUCHARD                                                   New Castle County Courthouse
   CHANCELLOR                                                       500 N. King Street, Suite 11400
                                                                   Wilmington, Delaware 19801-3734


                              Date Submitted: January 13, 2015
                               Date Decided: January 16, 2015



  Brian D. Long, Esquire
  Rigrodsky & Long, P.A.
  2 Righter Parkway, Suite 120
  Wilmington, DE 19803

         RE:    In re Zalicus, Inc. Stockholders Litigation
                Consolidated C.A. No. 9602-CB

  Dear Counsel:

         I have reviewed your letter dated January 13, 2015, notifying the Court that

  Defendant Zalicus, Inc. (“Zalicus”) has agreed to pay Plaintiffs’ counsel a “mootness fee”

  in the amount of $400,000, and requesting that I enter an order closing this case. For the

  following reasons, I decline to enter the proposed order because the parties have not

  given adequate notice of the stipulated mootness fee to the putative class.

         Plaintiffs filed this putative class action alleging that the directors of Zalicus had

  breached their fiduciary duties in connection with their approval of a stock-for-stock

  merger with Epirus Biopharmaceuticals, Inc. On June 13, 2014, I denied Plaintiffs’

  motion for expedited proceedings because I concluded that the claims presented in

  support of that motion were not colorable. On July 15, 2014, the stockholders of Zalicus

  approved the proposed merger, which closed that day.
In re Zalicus, Inc. Stockholders Litigation
Consol. C.A. No. 9602-CB
January 16, 2015
Page 2 of 5


       On November 12, 2014, I granted a stipulated order (the “Dismissal Order”) in

which the parties agreed that this action “is dismissed without prejudice as to all

plaintiffs” and that the Court would retain jurisdiction “solely for determining plaintiffs’

forthcoming Fee and Expense Application.”           When they filed the Dismissal Order,

Plaintiffs contended that supplemental disclosures by Zalicus had mooted certain of their

breach of fiduciary duty claims.

       On January 13, 2015, the parties agreed in a Stipulation Regarding Attorneys’

Fees and Expenses (the “Fee Stipulation”) that Zalicus (or its “successor(s) or applicable

insurer(s)”) would pay “a combined, global fee in the amount” of $400,000 to Plaintiffs’

counsel in this action and counsel for other Zalicus stockholders who commenced similar

litigation in Massachusetts “in full satisfaction of plaintiffs’ counsel’s claim for

attorney’s fees and expenses.” The parties now request that the Court enter another

stipulated order (the proposed “Closure Order”) providing that the Court no longer retain

jurisdiction over this action and that this action be closed for all purposes.

       Plaintiffs contend that “notice to the class should not be required” before the Court

may enter the Closure Order because the “Court need not approve or take any action with

respect to the Fee Stipulation.” Pls.’ Letter at 2, 3. Rather, according to Plaintiffs,

Zalicus has exercised its business judgment to expend corporate funds to resolve

Plaintiffs’ anticipated application for an award of attorney’s fees and expenses

concerning claims that have been mooted.
In re Zalicus, Inc. Stockholders Litigation
Consol. C.A. No. 9602-CB
January 16, 2015
Page 3 of 5


       Although it is true that the Court is not being asked to take any action with respect

to the Fee Stipulation, I conclude that, under this Court’s precedents, notice of the Fee

Stipulation nevertheless should be given to the putative class of Zalicus stockholders

before I may enter an order closing this case.

       Chancellor Allen’s opinion in Advanced Mammography sets forth the framework

for this Court to address a joint application to dismiss claims as moot and for a mootness

fee award. See In re Advanced Mammography Sys., Inc. S’holders Litig., 1996 WL

633409 (Del. Ch. Oct. 30, 1996). In Advanced Mammography, no notice of the joint

application had been given to the putative class. Chancellor Allen concluded that notice

of the joint application must be given to the putative class because of “the risk of buy off”

presented by the proposed fee payment. See id. at *1; see also In re Cellular Commc’ns

Int’l, Inc. S’holders Litig., 752 A.2d 1185, 1188 (Del. Ch. 2000) (citing Advanced

Mammography, 1996 WL 633409, at *1) (“Ordinarily, notice of the decision to dismiss

[claims on mootness grounds] and the terms of the [mootness] fee arrangement must be

disclosed to the class and a hearing held.”).

       Vice Chancellor Laster recently addressed a variation of this procedure in Astex,

where – similar to this case – the parties (i) agreed to dismiss the named plaintiffs’ claims

as moot with prejudice (but without prejudice to other members of the class); 1 (ii)


1
  As noted above, unlike Astex, paragraph 1 of the Dismissal Order in this case provides
that the action “is dismissed without prejudice to all plaintiffs.”
In re Zalicus, Inc. Stockholders Litigation
Consol. C.A. No. 9602-CB
January 16, 2015
Page 4 of 5


stipulated that the Court retain jurisdiction to hear the plaintiffs’ attorneys’ fees

application; (iii) subsequently agreed to a stipulated mootness fee; and (iv) moved to

have the Court close the case. See In re Astex Pharm., Inc. S’holders Litig., 2014 WL

4180342 (Del. Ch. Aug. 25, 2014). In Astex, no notice of the stipulated mootness fee had

been given to the class, which had been certified under Court of Chancery Rule 23.

Applying the principles of Advanced Mammography, Vice Chancellor Laster reasoned

that staggering the dismissal of claims and the agreement on fees “did not eliminate the

risk” of a buy off. See id. at *2. Thus, he denied the request to enter the proposed

closure order without first affording notice to the class of the stipulated mootness fee.

       I see no compelling reason why I should depart from Astex here. I am not

persuaded by Plaintiffs’ attempt to distinguish Astex on the grounds that no class has been

certified in this case. Plaintiffs have not explained why class certification should be

dispositive of whether notice is required under Advanced Mammography, and, in my

view, the existence of a certification order was irrelevant to the Court’s ruling in Astex.

In particular, I am hard-pressed to understand the relevance of a certification order in this

context where no members of the class have released any claims and the class members’

claims were dismissed without prejudice. To my mind, the rationale underlying Astex,

which is equally applicable here, is that notice is appropriate because it provides the

information necessary for an interested person to object to the use of corporate funds,

such as by “challeng[ing] the fee payment as waste in a separate litigation,” if the
In re Zalicus, Inc. Stockholders Litigation
Consol. C.A. No. 9602-CB
January 16, 2015
Page 5 of 5


circumstances warrant. See Hack v. Learning Co., 1996 WL 633309, at *2 (Del. Ch. Oct.

29, 1996).

       For the foregoing reasons, Plaintiffs’ motion to enter the proposed Closure Order

is DENIED. Should the parties elect to submit a revised order providing notice to the

members of the putative class, the parties are directed to explain (i) what form the notice

should take in these circumstances to be adequate while being sensitive to the cost

considerations of providing notice, and (ii) what, if any, further proceedings are

necessary before this action may be closed.

       IT IS SO ORDERED.

                                                 Sincerely,

                                                 /s/ Andre G. Bouchard

                                                 Chancellor

AGB/gp
cc:  Rudolf Koch, Esquire
     David J. Teklits, Esquire
     Ryan M. Ernst, Esquire
